Simcere Pharmaceutical eyes Hong Kong listing
China’s Simcere Pharmaceutical Group is seeking the green light to float on Hong Kong’s stock exchange after filing a listing application with the bourse.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: